Gastro Education 2018
Journal of Clinical Gastroenterology and Hepatology
ISSN: 2575-7733
Page 52
September 06-07, 2018
London, UK
14
th
International Conference on
Gastro Education
Introduction:
Portal hypertension is one of themain cause of post-
transplant graft dysfunction in living donor liver transplant (LDLT).
Modification of the portal flow has been suggested to decrease
portal pressure. One possible, splenic artery ligation (SAL), has
been performed in recipients with elevated portal vein flow. Even
though the short term results with SAL in LDLT are excellent, the
long term outcomes and postoperative complications have been
yet to be determined.
Methods:
From August 2010 to August 2016, 87 LDLT were
performed at the STI (Starzl Transplant Institute) of the University
of Pittsburgh. Two patients had previous splenectomy and were
excluded. Of 85 patients, 42 had SAL preformed. We compared
results in patients with SAL or without SAL retrospectively after
an IRB (institutional review board) approved by STI. LDLT was
performed using either the right or left lobe.
Results:
The study showed that SAL significantly decreased
mean portal pressure (19.2±1.7 pre-SAL vs 15±1.8 post-SAL,
p=0.0014). Of the 42 patients that had SAL, 7 (16.6%) developed
splenic infarction as noted on routine CT imaging, but only one
developed splenic abscess. No statistically difference was found
in postoperative infection, postoperative wound complication and
surgical complication rates between patients with/without SAL
(p=0.50,p=0.166, p=0.237). Although the mortality rate was lower
in patients with SAL, it was not statistically significant (11% vs
28%, p=0.059).
Conclusions:
Overall, SAL is safe and effective to decrease portal
pressure without increasing risk of morbidity and mortality in
recipient undergoing LDLT.
drygunay@gmail.comThe safety and efficacy of splenic artery ligation in living
donor liver transplant recipients
Yusuf Gunay
1
and
Abhinav Humar
2
1
Zonguldak Bulent Ecevit University, Turkey
2
Thomas E Starzl Transplant Institute – UPMC, USA
J Clin Gastroenterol Hepatol 2018, Volume 2
DOI: 10.21767/2575-7733-C2-006




